| P50 | author | Tanja A Stamm | Q88967262 |
| | Daniel Aletaha | Q92095812 |
| | Valerie P K Nell | Q114775962 |
| | Stephan Pflugbeil | Q114775963 |
| | Klaus P Machold | Q37381802 |
| | Josef S Smolen | Q66753681 |
| P2093 | author name string | Martin Uffmann | |
| P2860 | cites work | Reduced joint counts in controlled clinical trials in rheumatoid arthritis | Q72340180 |
| | Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity | Q72402072 |
| | Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis | Q73573994 |
| | Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis | Q74023924 |
| | Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study | Q74384496 |
| | Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings | Q74477379 |
| | Rheumatoid arthritis | Q74541001 |
| | ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology | Q74631253 |
| | Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis | Q77941215 |
| | Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease | Q78472006 |
| | Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events | Q79162998 |
| | The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis | Q80330544 |
| | Containing costs in chronic disease: monitoring strategies in the gold therapy of rheumatoid arthritis | Q33487567 |
| | Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score | Q33563148 |
| | Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis | Q33567552 |
| | The links between joint damage and disability in rheumatoid arthritis | Q33867923 |
| | Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial | Q33976382 |
| | World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. | Q34314560 |
| | Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 |
| | Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. | Q34317049 |
| | Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup | Q40636485 |
| | The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials | Q40914450 |
| | Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films | Q41513883 |
| | Patients with rheumatoid arthritis in clinical care | Q41828498 |
| | Long-term outcome of treating rheumatoid arthritis: results after 20 years | Q41913707 |
| | Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression | Q41915853 |
| | Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies | Q41918491 |
| | Effect sizes for interpreting changes in health status. | Q43872888 |
| | A simplified disease activity index for rheumatoid arthritis for use in clinical practice | Q44321551 |
| | Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial | Q44985061 |
| | Evaluative laboratory testing practices of United States rheumatologists. | Q45950546 |
| | High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. | Q46361196 |
| | American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 |
| | Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission | Q47863707 |
| | A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures. | Q52003345 |
| | A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. | Q52716513 |
| | The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT) | Q53395310 |
| | Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease | Q69667742 |
| | Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants | Q71628428 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | R796-806 | |
| P577 | publication date | 2005-04-07 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score | |
| P478 | volume | 7 | |